Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

Overview of attention for article published in The Lancet Rheumatology, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#2 of 902)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 278 news outlets
blogs: 3 blogs
policy: 2 policy sources

twitter: 628 X users
facebook: 1 Facebook page
f1000: 1 research highlight platform

Citations

dimensions_citation: 63 Dimensions

Readers on

mendeley: 157 Mendeley

Summary News Blogs Policy documents X Facebook Research highlights Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

TWiV 755: COVID-19 clinical update #62 with Dr. Daniel Griffin

This Week in Virology with Vincent Racaniello, 15 May 2021

In COVID-19 clinical update #62, Daniel Griffin covers outdoor transmission of the virus, safe use of NSAIDS, expansion of…

NSAID Use Not Linked to Increased Mortality, Severity in COVID-19

Physician's Weekly, 13 May 2021

WEDNESDAY, May 12, 2021 (HealthDay News) — Nonsteroidal anti-inflammatory drug (NSAID) use is not associated with increased…

Finalement, l’ibuprofène n’aggrave pas la Covid-19

GuruMeditation, 10 May 2021

Une nouvelle étude publiée fin de semaine dernière devrait soulager les personnes inquiètent d'avoir pris des analgésiques en…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.